Finally, we have the first results on the use of HBOT in the treatment of LONG COVID: they are more than good. READ IT
British researchers and experts in the field of hyperbaric medicine and oxygen therapy were the first to present official and concrete conclusions about the impact of the use of HBO therapy in patients suffering from LONG COVID syndrome (also known as "Post COVID 19 syndrome"), and the results of their research were published in the scientific journal Clinical Medical Journal, Royal College of Physicians London.
The study showed that patients with LONG COVID who underwent HBO treatments experienced significant improvement in all measured categories.
British scientists report that in patients (treated with HBO therapy) a reduction in fatigue symptoms (Chalder fatigue scale), improvement in cognitive abilities (global cognition), increase in attention and data processing speed (information processing speed), and improvement in higher-level cognitive processes, such as planning, decision-making, and problem solving (executive functions) were achieved.
The consequences of recovering from COVID 19 infection, included in the name LONG COVID or POST COVID syndrome, are a growing public health problem in the world, as well as in our country. It is expected that 10-20% of patients diagnosed with COVID 19 will have long-term adverse effects. Targeted treatment is not yet known. These results are encouraging and, as the authors themselves write, promising.
We can say that, based on our experience and knowledge of hyperbaric oxygen therapy and based on our previous knowledge of the pathophysiological mechanisms of the COVID 19 infection, we expected favorable results and were not surprised.
We follow the scientific literature and use it as our guide.
The full text of the scientific article is publicly available at the link https://www.rcpjournals.org/content/clinmedicine/21/6/e629